Etoposide in the treatment of hormone-refractory advanced carcinoma of the prostate

• Published in: Seminars in oncology Vol. 19; no. 6 Suppl 14; p. 53
• Main Authors: Crawford, E D, Daneshgari, F, Majeski, S A
• Format: Journal Article
• Language: English
• Published: United States 01.12.1992
• Subjects: Administration, Oral; Androgens - physiology; Etoposide - therapeutic use; Humans; Male; Prostatic Neoplasms - drug therapy; Prostatic Neoplasms - physiopathology; Treatment Outcome

The leading cause of cancer in males in the United States, prostate cancer accounts for 22% of all new cancers, with 132,000 new cases projected to be diagnosed in 1992. While localized prostate cancer can be cured, up to two thirds of patients present with advanced disease. Androgen deprivation rem...